Literature DB >> 1753266

A longitudinal evaluation of drug use in an ambulatory elderly population.

R B Stewart1, M T Moore, F E May, R G Marks, W E Hale.   

Abstract

Participants in a geriatric health screening program were studied longitudinally to determine the patterns of drug use over a 10 year period. There were 314 (34.0%) men and 610 (66.0%) women who completed 10 yearly health screening evaluations. The mean number of prescribed and non-prescribed drugs used per participant increased from 2.90 in 1978-79 to 4.08 in 1987-88 (p less than 0.0001). There was no significant difference between men and women in the rate of increased drug use. There was no significant increase in the mean number of drug ingredients per participant used over the 10 year period. The most frequently reported therapeutic categories for 1978-79 were antihypertensives, analgesic-antipyretics, antirheumatics, multiple vitamins, cathartics and vitamin E, which represented 10.2, 7.2, 6.5, 4.9, 4.8 and 3.8% of all categories used. There was a decline in all of these categories between interval 1 and 10. Increased use of drugs, particularly prescribed medications, by the elderly population may present problems of adverse drug reactions, drug interactions and medication compliance in the future. Changing patterns of drug use may have resulted, in part, from introduction of new therapeutic classes and from new treatment concepts over the 10 year study period.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1753266     DOI: 10.1016/0895-4356(91)90096-r

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  11 in total

1.  Changes in Drug Use and Polypharmacy After the Age of 90: A Longitudinal Study of the Danish 1905 Cohort.

Authors:  Jonas W Wastesson; Anna Oksuzyan; Jacob von Bornemann Hjelmborg; Kaare Christensen
Journal:  J Am Geriatr Soc       Date:  2016-11-28       Impact factor: 5.562

2.  Increasing use of medicines in elderly persons: a five-year follow-up of the Kuopio 75+Study.

Authors:  Johanna Jyrkkä; Leena Vartiainen; Sirpa Hartikainen; Raimo Sulkava; Hannes Enlund
Journal:  Eur J Clin Pharmacol       Date:  2006-01-12       Impact factor: 2.953

3.  Is it possible to reduce polypharmacy in the elderly? A randomised, controlled trial.

Authors:  K H Pitkala; T E Strandberg; R S Tilvis
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

Review 4.  Epidemiology of over-the-counter drug use in community dwelling elderly: United States perspective.

Authors:  J T Hanlon; G G Fillenbaum; C M Ruby; S Gray; A Bohannon
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

5.  Evolution of medication use in Jerusalem elders: Results from the Jerusalem Longitudinal Study.

Authors:  Michael A Steinman; Yoram Maaravi; Louise C Walter; Robert Hammerman-Rozenberg; Jochanan Stessman
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

6.  Qualitative insights into general practitioners views on polypharmacy.

Authors:  Sibyl Anthierens; Anneleen Tansens; Mirko Petrovic; Thierry Christiaens
Journal:  BMC Fam Pract       Date:  2010-09-15       Impact factor: 2.497

7.  Information on drug use in the elderly: a comparison of pharmacy, general-practitioner and patient data.

Authors:  E R Heerdink; H G Leufkens; C Koppedraaijer; A Bakker
Journal:  Pharm World Sci       Date:  1995-01-27

8.  Clinical implications of changes in hepatic drug metabolism in older people.

Authors:  Sarah N Hilmer; Gillian M Shenfield; David G Le Couteur
Journal:  Ther Clin Risk Manag       Date:  2005-06       Impact factor: 2.423

9.  Impact of missing data mechanism on the estimate of change: a case study on cognitive function and polypharmacy among older persons.

Authors:  Piia Lavikainen; Esko Leskinen; Sirpa Hartikainen; Jyrki Möttönen; Raimo Sulkava; Maarit J Korhonen
Journal:  Clin Epidemiol       Date:  2015-02-04       Impact factor: 4.790

Review 10.  Eszopiclone for late-life insomnia.

Authors:  Christina S McCrae; Amanda Ross; Ashley Stripling; Natalie D Dautovich
Journal:  Clin Interv Aging       Date:  2007       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.